Salmonella is one of the most widespread, resilient organisms and for many producers, may be a common cause of lost production on farms.

Veterinarians and producers now can protect pigs against two of the most virulent types of Salmonella with a single oral dose administered by the drinking water or oral drench.

Mike Steilen, BIVI brand manager, and Jessica Seate, DVM and BIVI technical manager, spoke to ThePigSite at World Pork Expo in early June.

Boehringer Ingelheim Vetmedica, Inc. (BIVI) has introduced a new swine enteric vaccine, Enterisol® Salmonella T/C. It's the only swine single-dose oral vaccine labeled as an aid in preventing disease due to Salmonella Choleraesuis and Salmonella Typhimurium when administered by drinking water.

Preventing both common types of Salmonella is the most effective way to protect pigs from disease, improve pig performance and increase farm profits.

Either type of Salmonella infection can be harmful to pigs and costly to producers.

• Salmonella Choleraesuis is more invasive and can result in septicaemia, bronchopneumonia and death. Although there are no food safety concerns with S. Choleraesuis, it is more devastating in terms of mortality and lost production.
• Salmonella Typhimurium infection is more localised. It causes diarrhea that can lead to dehydration and reduced performance. Because S. Typhimurium poses a food safety risk to humans, producers should be especially vigilant in preventing this disease.

Extensive field and research studies show the effectiveness and safety of Enterisol® Salmonella T/C in reducing the effects of disease in pigs exposed to S. Choleraesuis and S. Typhimurium. The two charts below show the results of the efficacy studies:

Immunisation, along with the implementation of proper sanitation programs, biosecurity protocols and diagnostic tools, can reduce the impact of salmonellosis in your swine herd, improve the safety of the pork you provide and increase farm profitability.